Skip Nav Destination
Issues
1 October 2006
-
Cover Image
Cover Image
Immunohistochemical staining of a rash biopsy derived from a metastatic melanoma patient 10 days after intralymphatic vaccination with melanoma tumor antigen-pulsed dendritic cells. Most of the study patients developed rashes in sun-exposed areas of skin following immunization. Rash biopsies were extensively infiltrated with CD3+ T lymphocytes (stained dark brown) that were also highly reactive against the immunizing tumor antigens. For further details, please see Grover et al. on page 5801 of this issue. - PDF Icon PDF LinkTable of Contents
ISSN 1078-0432
EISSN 1557-3265
Editor’s Note
Editorial
The Biology Behind
Molecular Pathways
Human Cancer Biology
Imaging, Diagnosis, Prognosis
Monitoring Tumor Glucose Utilization by Positron Emission Tomography for the Prediction of Treatment Response to Epidermal Growth Factor Receptor Kinase Inhibitors
Helen Su; Claudia Bodenstein; Rebecca A. Dumont; Yann Seimbille; Steven Dubinett; Michael E. Phelps; Harvey Herschman; Johannes Czernin; Wolfgang Weber
Does MYCN Amplification Manifested as Homogeneously Staining Regions at Diagnosis Predict a Worse Outcome in Children with Neuroblastoma? A Children's Oncology Group Study
Lisa A. Moreau; Patrick McGrady; Wendy B. London; Hiroyuki Shimada; Susan L. Cohn; John M. Maris; Lisa Diller; A. Thomas Look; Rani E. George
Extracellular pH and P-31 Magnetic Resonance Spectroscopic Variables are Related to Outcome in Canine Soft Tissue Sarcomas Treated with Thermoradiotherapy
Michaël Lora-Michiels; Daohai Yu; Linda Sanders; Jean M. Poulson; Chieko Azuma; Beth Case; Zeljko Vujaskovic; Donald E. Thrall; H. Cecil Charles; Mark W. Dewhirst
Identification of α-Enolase as an Autoantigen in Lung Cancer: Its Overexpression Is Associated with Clinical Outcomes
Gee-Chen Chang; Ko-Jiunn Liu; Chia-Ling Hsieh; Tsai-Shu Hu; Suparat Charoenfuprasert; Hsiung-Kun Liu; Kwen-Tay Luh; Li-Han Hsu; Chew-Wen Wu; Chou-Chik Ting; Chih-Yi Chen; Kun-Chieh Chen; Tsung-Ying Yang; Teh-Ying Chou; Wen-Hua Wang; Jacqueline Whang-Peng; Neng-Yao Shih
Cancer Therapy: Clinical
A Phase I and Pharmacokinetic Study of Temsirolimus (CCI-779) Administered Intravenously Daily for 5 Days Every 2 Weeks to Patients with Advanced Cancer
Manuel Hidalgo; Jan C. Buckner; Charles Erlichman; Marilyn S. Pollack; Joseph P. Boni; Gary Dukart; Bonnie Marshall; Lisa Speicher; Laurence Moore; Eric K. Rowinsky
Randomized Study of Paclitaxel and Tamoxifen Deposition into Human Brain Tumors: Implications for the Treatment of Metastatic Brain Tumors
Robert L. Fine; Johnson Chen; Casilda Balmaceda; Jeffrey N. Bruce; May Huang; Manisha Desai; Michael B. Sisti; Guy M. McKhann; Robert R. Goodman; Joseph S. Bertino, Jr.; Anne N. Nafziger; Michael R. Fetell
Phase I Study of Decitabine-Mediated Gene Expression in Patients with Cancers Involving the Lungs, Esophagus, or Pleura
David S. Schrump; Maria R. Fischette; Dao M. Nguyen; Ming Zhao; Xinmin Li; Tricia F. Kunst; Ana Hancox; Julie A. Hong; G. Aaron Chen; Vitaliy Pishchik; William D. Figg; Anthony J. Murgo; Seth M. Steinberg
Phase I Study of Bryostatin 1 and Fludarabine in Patients with Chronic Lymphocytic Leukemia and Indolent (Non-Hodgkin's) Lymphoma
John D. Roberts; Mitchell R. Smith; Eric J. Feldman; Louise Cragg; Michael M. Millenson; Gail J. Roboz; Connie Honeycutt; Rose Thune; Kristin Padavic-Shaller; W. Hans Carter; Viswanathan Ramakrishnan; Anthony J. Murgo; Steven Grant
Cancer Therapy: Preclinical
Multiparametric Flow Cytometric Analysis of Signal Transducer and Activator of Transcription 5 Phosphorylation in Immune Cell Subsets In vitro and following Interleukin-2 Immunotherapy
Kimberly A. Varker; Sri Vidya Kondadasula; Michael R. Go; Gregory B. Lesinski; Rupa Ghosh-Berkebile; Amy Lehman; J. Paul Monk; Thomas Olencki; Kari Kendra; William E. Carson, III
Cotreatment with Vorinostat (Suberoylanilide Hydroxamic Acid) Enhances Activity of Dasatinib (BMS-354825) against Imatinib Mesylate–Sensitive or Imatinib Mesylate–Resistant Chronic Myelogenous Leukemia Cells
Warren Fiskus; Michael Pranpat; Maria Balasis; Purva Bali; Veronica Estrella; Sandhya Kumaraswamy; Rekha Rao; Kathy Rocha; Bryan Herger; Francis Lee; Victoria Richon; Kapil Bhalla
MLN120B, a Novel IκB Kinase β Inhibitor, Blocks Multiple Myeloma Cell Growth In vitro and In vivo
Teru Hideshima; Paola Neri; Pierfranchesco Tassone; Hiroshi Yasui; Kenji Ishitsuka; Noopur Raje; Dharminder Chauhan; Klaus Podar; Constantine Mitsiades; Lenny Dang; Nikhil Munshi; Paul Richardson; David Schenkein; Kenneth C. Anderson
Cancer Susceptibility and Prevention
The Combination of the Rexinoid, LG100268, and a Selective Estrogen Receptor Modulator, Either Arzoxifene or Acolbifene, Synergizes in the Prevention and Treatment of Mammary Tumors in an Estrogen Receptor–Negative Model of Breast Cancer
Karen Liby; Mara Rendi; Nanjoo Suh; Darlene B. Royce; Renee Risingsong; Charlotte R. Williams; William Lamph; Fernand Labrie; Stan Krajewski; Xiaochun Xu; Heetae Kim; Powel Brown; Michael B. Sporn
Isodeoxyelephantopin, a Novel Sesquiterpene Lactone, Potentiates Apoptosis, Inhibits Invasion, and Abolishes Osteoclastogenesis through Suppression of Nuclear Factor-κB (NF-κB) Activation and NF-κB-Regulated Gene Expression
Haruyo Ichikawa; Mangalam S. Nair; Yasunari Takada; D.B. Alan Sheeja; M.A. Suresh Kumar; Oommen V. Oommen; Bharat B. Aggarwal
Advertisement
Email alerts
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale within the United States of Bavencio® (avelumab), a pharmaceutical owned by Merck. If any resulting funds are received, they would not be used to directly support any specific publication or author. If an individual article is published that deals with this particular drug, such article will include standard financial disclosures per AACR journal policy. For more detail regarding AACR’s established policies for authors, please go to https://aacrjournals.org/pages/editorial-policies#coi.